Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Self-Powered Ingestible Sensor Offers Smarter Way to Measure Critical Intestinal Activity

By HospiMedica International staff writers
Posted on 05 Dec 2022

Approximately 20% of people will suffer from gastrointestinal disorders at some point in their lives. More...

These may include inflammatory bowel disease (IBD), diabetes or obesity, all caused, in part, by the dysfunction of the intestinal processes involving the absorption or digestion of gut metabolites. Such maladies represent a significant cost to the economy and strain on healthcare systems. Therefore, the stakes of accessing information from the relevant sections of the GI tract are quite high. Older methods for directly monitoring the inside of the small intestine can cause significant discomfort for patients while generating only single short data recordings of an environment that continuously changes. Now, engineering researchers have developed a battery-free, pill-shaped ingestible biosensing system to provide continuous monitoring in the intestinal environment. It gives scientists the ability to monitor gut metabolites in real time, which wasn’t possible before. This feat of technological integration could unlock new understanding of intestinal metabolite composition, which significantly impacts human health overall.

The ingestible, biofuel-driven sensor developed by engineers at the University of California San Diego (San Diego, CA, USA) facilitates in-situ access to the small intestine, making glucose monitoring easier while generating continuous results. These measurements provide a critical component of tracking overall gastrointestinal health, a major factor in studying nutrition, diagnosing and treating various diseases, preventing obesity, and more. In contrast to the older methods, this biosensor provides access to continuous data readings over time. The platform could also be used to develop new ways to study the microbiome of the small intestine. The “smart pill” approach could lead to simpler and cheaper ways to monitor the small intestine, which could lead to significant cost savings in the future.

Instead of a battery, this “smart pill” is powered by a non-toxic fuel cell that runs on glucose. The researchers developed a self-powered glucose biofuel biosensor integrated into a circuit that performs energy harvesting, biosensing and wireless telemetry using a power-to-frequency conversion scheme utilizing magnetic human body communication. The unique battery-free operation is made possible by the team's glucose biofuel cell (BFC) for obtaining power during operation while simultaneously measuring changing glucose concentrations. Its energy-efficient magnetic human body communication (mHBC) scheme operates in the 40-200 MHz range to receive the time-resolved transmitted signals.

The proof-of-concept smart pill measures 2.6 cm in length and 0.9 cm in diameter. So far, small intestine data recording has only been performed in pigs, which have a similar size GI tract to humans. Having achieved promising results in these experiments, the researchers now plan to increase the number of sensors available in the pills. This will enable monitoring of still more chemical parameters in the intestines. They also plan to further miniaturize the sensors and electronic circuitry to match what is currently available in the smart-pill market.

“In our experiments, the battery-free biosensor technology continuously monitored glucose levels in the small intestines of pigs 14 hours after ingestion, yielding measurements every five seconds for two to five hours,” said Ernesto De La Paz Andres, a nanoengineering graduate student at UC San Diego. “Our next step is to reduce the size of the pills from the current 2.6 cm in length so they will be easier for human subjects to swallow.”

“Currently, the way to sample fluid inside the stomach and intestines is to do an endoscopy, where a catheter is inserted down your throat and into your GI tract by a doctor,” said Patrick Mercier, a professor of electrical and computer engineering at UC San Diego who led the team along with nanoengineering professor Joseph Wang. "By combining the ultra-low-power circuit and wireless technologies from my lab with glucose-powered fuel cell and cutting-edge electrochemical sensing from the lab of UC San Diego nanoengineering professor Joseph Wang, we have an opportunity to create new modalities for understanding what is happening in the small intestine."

“With our battery-free smart pill approach, we have opportunities to monitor the small intestine for much longer than just a moment," said Wang. "We also plan to add additional sensors to the system. Our goal is to develop a sensing platform for the intestine that allows for the collection of many different kinds of information over longer periods of time. We are working to show that there is so much opportunity to discover what is really happening in the small intestine. I hope this kind of information will be useful for better understanding the role that changes in the small intestine environment play in health and disease.”

Related Links:
UC San Diego


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.